Langheinrich Melanie C, Schellerer Vera, Perrakis Aristotelis, Lohmüller Clemens, Schildberg Claus, Naschberger Elisabeth, Stürzl Michael, Hohenberger Werner, Croner Roland S
Department of Surgery, University Hospital Erlangen, Germany.
Int J Clin Exp Pathol. 2012;5(7):614-23. Epub 2012 Sep 5.
Tumor cell dissemination from the primary tumor site to distant organs is one of the characteristic properties of malignant tumors and represents a crucial step in the progression of disease. Although the pattern of spread may vary in different types of carcinomas, dissemination via the lymphatic system represents a common event in metastasis. The extent of lymph node metastasis is one of the major determinants for the prognosis of patients with gastrointestinal carcinomas and guides the therapeutically management. During the last decades, significant attention has been given to the molecular mechanisms that control lymphatic metastasis. The process of lymphangiogenesis has come into the focus. Lymphangiogenesis, the formation of newly lymphatics, comprises a series of complex cellular events and is controlled by a balance between pro- and anti-lymphangiogenic signals. This article will briefly describe the lymphatic system and then provide an overview of the molecular players involved in tumor lymphangiogenesis.
肿瘤细胞从原发肿瘤部位扩散至远处器官是恶性肿瘤的特征之一,也是疾病进展中的关键步骤。尽管不同类型的癌扩散模式可能有所不同,但通过淋巴系统扩散是转移过程中的常见现象。淋巴结转移程度是胃肠道癌患者预后的主要决定因素之一,并指导治疗管理。在过去几十年中,人们对控制淋巴转移的分子机制给予了极大关注。淋巴管生成过程已成为焦点。淋巴管生成即新淋巴管的形成,包括一系列复杂的细胞事件,并由促淋巴管生成信号和抗淋巴管生成信号之间的平衡所控制。本文将简要描述淋巴系统,然后概述参与肿瘤淋巴管生成的分子因素。